Our Product
Learn more about this FDA-approved product and its novel mechanism of action.
Verona Pharma announces the FDA approval of Ohtuvayre™ (ensifentrine) a new inhaled treatment.
Donec sed odio dui. Vestibulum id ligula porta felis euismod semper. Maecenas sed diam eget risus varius blandit sit amet non magna. Vestibulum id ligula porta felis euismod semper.
PRO-OHT-1754-v1 06/2024
We welcome enquires from healthcare professionals.